Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Award
Common Stock
2025-03-14+238,000→ 485,245 total - Award
Stock Option (right to buy)
2025-03-14+213,000→ 213,000 totalExercise: $1.50Exp: 2035-03-14→ Common Stock (213,000 underlying)
Footnotes (2)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be in June 15, 2025.
- [F2]Includes 6,574 shares recently acquired in Esperion's Employee Stock Purchase Plan.